Study summary

The purpose of this study is to evaluate the long-term safety and efficacy of ASP015K in subjects with Rheumatoid Arthritis (RA) who have completed a preceding Phase 2 ASP015K RA study.

Additional Study Details

Phase
2
Product
  • peficitinib
  • Type
    Interventional
    Masking
    None (Open Label)
    Enrollment number
    611
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      Site HU3448
      Budapest, Hungary, 1027
      Completed
      Site CO3450
      Bucaramanga, Colombia
      Completed
      Site US291
      Wheaton, MD, United States, 20902
      Completed
      Site US219
      Palo Alto, CA, United States, 94304
      Completed
      Site US3218
      Birmingham, AL, United States, 35216
      Completed
      Site US3300
      Oklahoma City, OK, United States, 73103
      Completed
      Site US3226
      Vernon Hills, IL, United States, 60061
      Completed
      Site MX3317
      Morelia, Mexico, 58070
      Completed
      Site MX3238
      Guadalajara, Mexico, 44650
      Completed
      Site HU3398
      Bekescsaba, Hungary, 5600
      Completed
      Site CZ3449
      Zlin, Czech Republic, 760 01
      Completed
      Site HU3462
      Budapest, Hungary, 1027
      Completed
      Site PL3391
      Bialystok, Poland, 15-879
      Completed
      Site US3298
      Hickory, NC, United States, 28602
      Completed
      Site CO3451
      Cali, Colombia
      Completed
      Site US3319
      Austin, TX, United States, 78705
      Completed
      Site BG3613
      Burgas, Bulgaria, 8000
      Completed
      Site US3232
      Orlando, FL, United States, 32804
      Completed
      Site HU3302
      Budapest, Hungary, 1027
      Completed
      Site PL3600
      Warszawa, Poland, 02-118
      Completed
      Site PL2893
      Bydgoszcz, Poland, 85-168
      Completed
      Site US3306
      Knoxville, TN, United States, 37909
      Completed
      Site PL3233
      Bialystok, Polska, Poland, 15-351
      Completed
      Site US702
      Morton Grove, IL, United States, 60053
      Completed
      Site CZ3388
      Praha 2, Czech Republic, 128 50
      Completed
      Site US3227
      Palm Desert, CA, United States, 92260
      Completed
      Site PL3599
      Warszawa, Poland, 02-653
      Completed
      Site US3329
      Elizabethtown, KY, United States, 42701
      Completed
      Site BG3303
      Sofia, Bulgaria, 1612
      Completed
      Site CO2826
      Bucamaranga, Colombia
      Completed
      Site US345
      Duncansville, PA, United States, 16635
      Completed
      Site US3304
      Wyomissing, PA, United States, 19610
      Completed
      Site MX3307
      Guadalajara, Jalisco, Mexico, 44280
      Completed
      Site CZ3225
      Uherske Hradiste, Czech Republic, 68601
      Completed
      Site PL3601
      Lublin, Poland, 20-582
      Completed
      Site BE3314
      Brussels, Belgium, 1190
      Completed
      Site PL3603
      Krakow, Poland, 31-637
      Completed
      Site US3327
      Chesapeake, VA, United States, 23320
      Completed
      Site MX3310
      Mexico, Mexico, 6700
      Completed
      Site CZ3376
      Praha-Nusle, Czech Republic, 140 00
      Completed
      Site HU3447
      Debrecen, Hungary, H-4043
      Completed
      Site BE3387
      Brussels, Belgium, 1070
      Completed
      Site CO3297
      Bogota, Colombia
      Completed
      Site US3331
      Colorado Springs, CO, United States, 80920
      Completed
      Site US3320
      Clarksburg, WV, United States, 26301
      Completed
      Site US3332
      Santa Maria, CA, United States, 93454
      Completed
      Site US828
      LaJolla, CA, United States, 92093-0943
      Completed
      Site US1894
      Jacksonville, FL, United States, 32216
      Completed
      Site BG3217
      Plovdiv, Bulgaria, 4003
      Completed
      Site CO3326
      Barranquilla, Atlantico, Colombia
      Completed
      Site HU3461
      Balatonfüred, Hungary, 8230

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?